Clinical Trials in Australia / NCT03773965
Recruiting
Phase 3
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
NCT03773965 · tracked via the Priya Life Science Australia tracker
Condition(s) studied
Juvenile Idiopathic Arthritis
Study summary
The reason for this study is to see if the study drug baricitinib is safe and effective in the treatment of JIA in participants ages 1 to 17. This study is for participants that have been enrolled in studies I4V-MC-JAHV (NCT03773978) or I4V-MC-JAHU.
Eligibility
Inclusion Criteria:
* Participants must have completed a previous study of baricitinib for the treatment of JIA.
Exclusion Criteria:
* Participants must not have had a permanent discontinuation of baricitinib in the prior study.
* Participants must have not developed an allergy to baricitinib.
Primary outcome measure(s)
- Number of Participants with One or More Serious Adverse Event(s) (SAEs) — Baseline through Week 264
Number of participants with one or more SAEs - Number of Participants with Permanent Investigational Product Discontinuations — Baseline through Week 264
Number of participants with permanent investigational product discontinuations
Trial sites (78)
| Facility | City | Region | Status |
|---|---|---|---|
| Instituto CAICI SRL | Rosario | Argentina | Active Not Recruiting |
| Centro de Investigaciones Médicas Tucuman | SAN M. de Tucuman | Argentina | Active Not Recruiting |
| Royal Children's Hospital | Melbourne | Australia | Not Yet Recruiting |
| Perth Children's Hospital | Perth | Australia | Not Yet Recruiting |
| The Children's Hospital at Westmead | Westmead | Australia | Active Not Recruiting |
| Landeskrankenhaus Bregenz | Bregenz | Austria | Completed |
| Cliniques universitaires Saint-Luc | Brussels | Belgium | Completed |
| UZ Gent | Ghent | Belgium | Recruiting |
| UZ Leuven | Leuven | Belgium | Recruiting |
| Faculdade de Medicina da UNESP | Botucatu | Brazil | Recruiting |
| Universidade Federal de Sao Paulo | São Paulo | Brazil | Recruiting |
| Instituto da Crianca do Hospital das Clinicas da FMUSP | São Paulo | Brazil | Recruiting |
| Beijing Children's hospital, Capital Medical University | Beijing | China | Active Not Recruiting |
| The Children's Hospital of Chongqing Medical University | Chongqing | China | Active Not Recruiting |
| Childrens Hospital of Nanjing Medical University | Nanjing | China | Not Yet Recruiting |
| Children's Hospital of Soochow University | Suzhou | China | Recruiting |
| Detska nemocnice FN Brno | Brno | Czechia | Recruiting |
| Vseobecna fakultni nemocnice v Praze | Prague | Czechia | Recruiting |
| Fakultni nemocnice Motol | Prague | Czechia | Recruiting |
| Aarhus Universitetshospital, Skejby | Aarhus | Denmark | Recruiting |
| Hospices Civils de Lyon - Hôpital Femme Mère Enfant | Bron | France | Recruiting |
| Hôpitaux Universitaires Paris Sud - Hôpital Bicêtre | Le Kremlin-Bicêtre | France | Recruiting |
| Centre Hospitalier Universitaire de Nîmes - Hôpital Universitaire Carémeau | Nîmes | France | Recruiting |
| Hôpital Universitaire Necker Enfants Malades | Paris | France | Recruiting |
| Centre Hospitalier Universitaire de Poitiers | Poitiers | France | Recruiting |
| Helios Klinikum Berlin-Buch | Berlin | Germany | Active Not Recruiting |
| Charité Campus Virchow-Klinikum | Berlin | Germany | Completed |
| Praxis Kinder- und Jugendrheumatologie Dr. Ivan Foeldvari | Hamburg | Germany | Active Not Recruiting |
| Universitätsklinikum Heidelberg | Heidelberg | Germany | Completed |
| Asklepios Klinik Sankt Augustin | Sankt Augustin | Germany | Active Not Recruiting |
| Universitaetsklinikum Tuebingen | Tübingen | Germany | Active Not Recruiting |
| Sri Ramachandra MedicaL College & Research Institute | Chennai | India | Completed |
| Sir Ganga Ram Hospital | New Delhi | India | Recruiting |
| Christian Medical College Vellore | Vellore | India | Recruiting |
| Rambam Health Care Campus | Haifa | Israel | Recruiting |
| Meir Medical Center | Kfar Saba | Israel | Recruiting |
| Schneider Children's Medical Center | Petah Tikva | Israel | Recruiting |
| Sheba Medical Center | Ramat Gan | Israel | Recruiting |
| Azienda Ospedaliera Spedali Civili di Brescia | Brescia | Italy | Active Not Recruiting |
| Azienda Sanitaria Locale n. 2 - Lanciano Vasto Chieti | Chieti | Italy | Completed |
+ 38 more sites — see the full list on the official registry below.
On this site
📄 Olumiant (baricitinib) drug profile →More Eli Lilly and Company trials in Australia
A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)
Active, not recruiting
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03773965 on ClinicalTrials.gov ↗ ← All trials in Australia